Emeryville, United States
Eko Health, founded in 2013, is a frontrunner in the digital health and medical devices industries, bringing significant advancements in detecting and monitoring heart and lung diseases. The company's signature offering includes a portfolio of digital stethoscopes and AI-powered software, enhancing the diagnostic capabilities of healthcare professionals globally. The platform, cleared by the FDA, has already permeated the market with over 650,000 units sold worldwide, promising earlier detection and improved patient care.
With headquarters in Emeryville, California, Eko Health has attracted substantial financial backing, amounting to over $165 million in funding from prominent investors like ARTIS Ventures, DigiTx Partners, and Mayo Clinic. In its latest Series D funding round on June 5, 2024, the company secured an additional $41 million from investors including Highland Capital Partners and NTT VC. This financial influx positions Eko Health favorably for future growth.
